GlassScriptPhysician profile
Pooja Nowlakha
NPI 1710395488
$5,738.26
in general payments reported to CMS, 2019-2025
30 companies · $550 in 2025
The $550 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,108 · 2020: $1,130 · 2021: $2,063 · 2022: $655 · 2023: $100 · 2024: $132 · 2025: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $502 · Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $501.97 |
| Food and Beverage | $280.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,726.72 | 2019-2022 | |
| Treace Medical Concepts, INC. | $1,289.23 | 2021-2025 | |
| Smith+Nephew, INC. | $871.67 | 2019-2025 | Collagenase Santyl, Renasys Go V2 Home |
| Kerecis Limited | $486.99 | 2019-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Novo Nordisk INC | $224.86 | 2019-2022 | |
| Sanara Medtech INC. | $155.45 | 2021 | |
| Bone Support INC. | $143.75 | 2022 | |
| Kci USA, INC. | $116.86 | 2019 | |
| Paragon 28, INC. | $88.07 | 2019 | |
| Aroa Biosurgery Incorporated | $72.72 | 2019-2022 | |
| Melinta Therapeutics, LLC | $66.61 | 2019-2020 | |
| Lilly USA, LLC | $62.44 | 2020-2021 | |
| Organogenesis INC. | $61.51 | 2020-2021 | |
| Musculoskeletal Transplant Foundation INC. | $45.12 | 2021 | |
| Paratek Pharmaceuticals, INC. | $35.16 | 2024 | Nuzyra |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $32.63 | 2022 | |
| Ets Wound Care LLC | $27.22 | 2023 | |
| Zyla Life Sciences, INC. | $25.63 | 2020 | |
| Hydrofera LLC | $22.52 | 2022 | |
| Grt US Holding, INC. | $20.60 | 2022 | |
| Medtronic, INC. | $20.20 | 2024 | Intellis Adaptivestim |
| Abbvie INC. | $18.93 | 2021 | |
| Redhill Biopharma INC. | $18.21 | 2020 | |
| Abbott Laboratories | $16.70 | 2022 | |
| Amgen INC. | $16.30 | 2025 | Krystexxa |
| Bioventus LLC | $16.28 | 2023 | Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $15.75 | 2021 | |
| Integra Lifesciences Corporation | $14.05 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.05 | 2022 | |
| Extremity Medical | $13.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pooja Nowlakha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.